These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 19141681)

  • 1. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
    Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
    Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation.
    Holloway GP; Snook LA; Harris RJ; Glatz JF; Luiken JJ; Bonen A
    J Physiol; 2011 Jan; 589(Pt 1):169-80. PubMed ID: 21041527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats.
    Chabowski A; Chatham JC; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E675-82. PubMed ID: 16684853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.
    Bonen A; Parolin ML; Steinberg GR; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ; Dyck DJ
    FASEB J; 2004 Jul; 18(10):1144-6. PubMed ID: 15132977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle.
    Holloway GP; Jain SS; Bezaire V; Han XX; Glatz JF; Luiken JJ; Harper ME; Bonen A
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R960-7. PubMed ID: 19625692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscle.
    Bezaire V; Heigenhauser GJ; Spriet LL
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E85-91. PubMed ID: 12954596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.
    Holloway GP; Bezaire V; Heigenhauser GJ; Tandon NN; Glatz JF; Luiken JJ; Bonen A; Spriet LL
    J Physiol; 2006 Feb; 571(Pt 1):201-10. PubMed ID: 16357012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.
    Bonen A; Holloway GP; Tandon NN; Han XX; McFarlan J; Glatz JF; Luiken JJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1202-12. PubMed ID: 19675275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.
    Bruce CR; Thrush AB; Mertz VA; Bezaire V; Chabowski A; Heigenhauser GJ; Dyck DJ
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E99-E107. PubMed ID: 16464906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
    Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
    Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
    Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.
    Bruce CR; Brolin C; Turner N; Cleasby ME; van der Leij FR; Cooney GJ; Kraegen EW
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1231-7. PubMed ID: 17179390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria.
    Benton CR; Nickerson JG; Lally J; Han XX; Holloway GP; Glatz JF; Luiken JJ; Graham TE; Heikkila JJ; Bonen A
    J Biol Chem; 2008 Feb; 283(7):4228-40. PubMed ID: 18079123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats.
    Steinberg GR; Bonen A; Dyck DJ
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E593-600. PubMed ID: 11832362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-intensity interval training increases intrinsic rates of mitochondrial fatty acid oxidation in rat red and white skeletal muscle.
    Hoshino D; Yoshida Y; Kitaoka Y; Hatta H; Bonen A
    Appl Physiol Nutr Metab; 2013 Mar; 38(3):326-33. PubMed ID: 23537026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria.
    Benton CR; Holloway GP; Campbell SE; Yoshida Y; Tandon NN; Glatz JF; Luiken JJ; Spriet LL; Bonen A
    J Physiol; 2008 Mar; 586(6):1755-66. PubMed ID: 18238811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle.
    Han XX; Chabowski A; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E566-75. PubMed ID: 17519284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
    Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
    J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.